In the Longest-Running Post-Marketing Surveillance Study of Its Type, Data at 24 Months on FDgard®, Presented at The American College of Gastroenterology (ACG) Annual Meeting, Confirms Excellent Safety and Tolerability Profile of This Nonprescription Product for Functional Dyspepsia (Meal-Triggered, Recurring Indigestion)

October 29, 2019

Data at 24 Months on FDgard®, Presented at The American College of Gastroenterology (ACG) Annual Meeting, Confirms Excellent Safety and Tolerability Profile of This Nonprescription Product for Functional Dyspepsia (Meal-Triggered, Recurring Indigestion)

Read More

Peer-Reviewed Medical Journal Publishes Landmark Study on Efficacy and Safety of FDgard® (COLM-SST), Demonstrating Rapid Reduction of Functional Dyspepsia (FD or Recurring, Meal-Triggered Indigestion) Symptoms within 24 Hours

April 30, 2019

Peer-Reviewed Medical Journal Publishes Landmark Study on Efficacy and Safety of FDgard® (COLM-SST), Demonstrating Rapid Reduction of Functional Dyspepsia (FD or Recurring, Meal-Triggered Indigestion) Symptoms within 24 Hours.

Read More

For The Second Year In A Row, Gastroenterologists Nationwide Endorse Non-Prescription FDgard® For Functional Dyspepsia (Meal-Triggered Indigestion)

July 3, 2018

For the second year in a row, gastroenterologists nationwide endorse non-prescription FDgard® for Functional Dyspepsia (meal-triggered indigestion).

Read More

U.S. Gastroenterologists Endorse Non-Prescription FDgard® for Functional Dyspepsia (Recurring Indigestion)

November 1, 2017

U.S. Gastroenterologists Endorse Non-Prescription FDgard® for Functional Dyspepsia (Recurring Indigestion)

Read More

Final Results of Real-World Data from Observational Study Underscore High Levels of Patient Satisfaction and Rapid Improvement of Functional Dyspepsia (Recurring Indigestion) with Non-Prescription FDgard®

October 18, 2017

Final Results of Real-World Data from Observational Study Underscores High Levels of Patient Satisfaction and Rapid Improvement of Functional Dyspepsia (Recurring Indigestion) with Non-Prescription FDgard®

Read More

Real-World Data from Surveillance Study at 12 Months Confirms Excellent Safety and Tolerability Profile of New, Non-Prescription FDgard® for Functional Dyspepsia

August 24, 2017

Real-World Data from Surveillance Study at 12 months Confirms Excellent Safety and Tolerability Profile of New, Non-prescription FDgard® for Functional Dyspepsia

Read More

Caret Pharma to Acquire Fiber Choice®

August 21, 2017

Caret Pharma to Acquire Fiber Choice®

Read More

Results of New Clinical Data Presented at Digestive Disease Week (DDW), a Premier Gastroenterology Meeting, Show Unprecedented Symptom Reduction and Rapid Relief of Functional Dyspepsia (FD – Persistent or Recurring Indigestion) with FDgard®, a New Product for This Condition

May 8, 2017

Results Of New Clinical Data Presented At Digestive Disease Week (DDW), A Premiere Gastroenterology Meeting, Show Unprecedented Symptom Reduction And Rapid Relief Of Functional Dyspepsia (FD – Persistent Or Recurring Indigestion) With FDgard®, A New Product For This Condition

Read More

Real-World Data from Surveillance Study Confirms Excellent Safety and Tolerability Profile of New, Non-Prescription FDgard® for Functional Dyspepsia (Non-Heartburn Indigestion)

April 3, 2017

Real-World Data From Surveillance Study Confirms Excellent Safety And Tolerability Profile Of New, Non-Prescription Fdgard® For Functional Dyspepsia (Non-Heartburn Indigestion)

Read More